Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Self-citationNeuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Self-citationPerkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Self-citationQuinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751 · cited 1×
“In addition, 3-HK and its degradation product, the immediate QUIN bioprecursor 3-hydroxyanthranilic acid, generate superoxide and hydrogen peroxide in a copper-dependent manner and thus promote copper-dependent, oxidative protein damage (Goldstein et al., 2000).”
BackgroundKessler, M., Terramani, T., Lynch, G., & Baudry, M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb01881.x · Cited by 739
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Self-citationKynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
II. Excitotoxic models for neurodegenerative disorders
Schwarcz, R., Foster, A. C., French, E. D., Whetsell, W. O., & Köhler, C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90148-6 · Cited by 466
Self-citationOkuda, S., Nishiyama, N., Saito, H., & Katsuki, H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010299.x · Cited by 462
Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Foster, A. C., Vezzani, A., French, E. D., & Schwarcz, R. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90050-8 · Cited by 434
Self-citationBeal, M. F., Matson, W. R., Swartz, K. J., Gamache, P. H., & Bird, E. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03143.x · Cited by 311
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance
Stone, T. W. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00032-0 · Cited by 306
Presence of Kynurenic Acid in the Mammalian Brain
Moroni, F., Russi, P., Lombardi, G., Beni, M., & Carlà, V. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04852.x · Cited by 278
Quinolinic acid is a potent lipid peroxidant in rat brain homogenates
Rios, C., & Santamaria, A. (1991) · Neurochemical Research · doi:10.1007/bf00966592 · Cited by 271
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid
HEYES, M. P., ACHIM, C. L., WILEY, C. A., MAJOR, E. O., SAITO, K., & MARKEY, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260
Presynaptic kynurenate‐sensitive receptors inhibit glutamate release
Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254
Characterization of rat brain kynurenine aminotransferases I and II
Guidetti, P., Okuno, E., & Schwarcz, R. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971101)50:3<457::aid-jnr12>3.0.co;2-3 · Cited by 233
Self-citationRöver, S., Cesura, A. M., Huguenin, P., Kettler, R., & Szente, A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970467t · Cited by 211
Goldstein, L. E., Leopold, M. C., Huang, X., Atwood, C. S., Saunders, A. J., Hartshorn, M., Lim, J. T., Faget, K. Y., Muffat, J. A., Scarpa, R. C., et al. (2000) · Biochemistry · doi:10.1021/bi992997s · Cited by 211
Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice
Lapin, I. P. (1978) · Journal of Neural Transmission · doi:10.1007/bf01262727 · Cited by 193
3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum
Guidetti, P., & Schwarcz, R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180
Self-citationWhetsell, W. O., & Schwarcz, R. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90609-5 · Cited by 175
Self-citationHeyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., & Vickers, J. H. (1993) · Brain · doi:10.1093/brain/116.6.1425 · Cited by 170
Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line
Eastman, C. L., & Guilarte, T. R. (1989) · Brain Research · doi:10.1016/0006-8993(89)90216-3 · Cited by 161
Carpenedo, R., Chiarugi, A., Russi, P., Lombardi, G., Carlà, V., Pellicciari, R., Mattoli, L., & Moroni, F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90227-5 · Cited by 159
Self-citationCozzi, A., Carpenedo, R., & Moroni, F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00007 · Cited by 159
de Carvalho, L. P., Bochet, P., & Rossier, J. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00091-7 · Cited by 144
Pellicciari, R., Natalini, B., Costantino, G., Mahmoud, M. R., Mattoli, L., Sadeghpour, B. M., Moroni, F., Chiarugi, A., & Carpenedo, R. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a015 · Cited by 136
Self-citationKerr, S. J., Armati, P. J., Guillemin, G. J., & Brew, B. J. (1998) · AIDS · doi:10.1097/00002030-199804000-00003 · Cited by 132
Quinolinic acid accumulation and functional deficits following experimental spinal cord injury
Blight, A. R., Cohen, T. I., Saito, K., & Heyes, M. P. (1995) · Brain · doi:10.1093/brain/118.3.735 · Cited by 108
Uptake of Kynurenine into Rat Brain Slices
Speciale, C., & Schwarcz, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13296.x · Cited by 106
Self-citationBrain‐Specific Modulation of Kynurenic Acid Synthesis in the Rat
Gramsbergen, J. B. P., Hodgkins, P. S., Rassoulpour, A., Turski, W. A., Guidetti, P., & Schwarcz, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010290.x · Cited by 105
Self-citationChiarugi, A., Carpenedo, R., Molina, M. T., Mattoli, L., Pellicciari, R., & Moroni, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031176.x · Cited by 105
Self-citationSpeciale, C., Wu, H., Cini, M., Marconi, M., Varasi, M., & Schwarcz, R. M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00613-9 · Cited by 104
Self-citationMoroni, F., Russi, P., Gallo‐Mezo, M. A., Moneti, G., & Pellicciari, R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06361.x · Cited by 102
Self-citationGuidetti, P., Eastman, C. L., & Schwarcz, R. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062621.x · Cited by 100
Self-citationSaito, K., Chen, C. Y., Masana, M., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993) · Biochemical Journal · doi:10.1042/bj2910011 · Cited by 97
Wu, H., Guidetti, P., Goodman, J. H., Varasi, M., Ceresoli‐Borroni, G., Speciale, C., Scharfman, H. E., & Schwarcz, R. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00030-0 · Cited by 80
Self-citationPharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons
Erhardt, S., Öberg, H., Mathé, J. M., & Engberg, G. (2001) · Amino Acids · doi:10.1007/s007260170032 · Cited by 74
Eguchi, N., Watanabe, Y., Kawanishi, K., Hashimoto, Y., & Hayaishi, O. (1984) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(84)90579-4 · Cited by 73
Dua, R. K., Taylor, E. W., & Phillips, R. S. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00057a007 · Cited by 67
On the disposition of intrahippocampally injected kynurenic acid in the rat
Turski, W. A., & Schwarcz, R. M. (1988) · Experimental Brain Research · doi:10.1007/bf00248748 · Cited by 66
Self-citationPöeggeler, B., Rassoulpour, A., Guidetti, P., Wu, H., & Schwarcz, R. M. (1998) · Developmental Neuroscience · doi:10.1159/000017309 · Cited by 57
Self-citationWalsh, J. L., Todd, W. P., Carpenter, B. K., & Schwarcz, R. M. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90279-e · Cited by 51
Self-citationSalter, M., Hazelwood, R., Pogson, C. I., Iyer, R. N., Madge, D. J., Jones, H. T., Cooper, B. R., Cox, R. F., Wang, C. M., & Wiard, R. P. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00147-k · Cited by 41
Chiarugi, A., & Moroni, F. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00048-9 · Cited by 40
Quinolinic Acid in Neurological Disease: Opportunities for Novel Drug Discovery
Reinhard, J. F., Erickson, J. B., & Flanagan, E. M. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60173-8 · Cited by 39
2‐Oxoacids Regulate Kynurenic Acid Production in the Rat Brain: Studies In Vitro and In Vivo
Hodgkins, P., Wu, H., Zielke, R. H., & Schwarcz, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720643.x · Cited by 39
Self-citationScharfman, H. E., Hodgkins, P., Lee, S.-C., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00690-4 · Cited by 38
Guidetti, P., Wu, H., & Schwarcz, R. M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7284 · Cited by 32
Self-citation4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase
Giordani, A., Pevarello, P., Cini, M., Bormetti, R., Greco, F., Toma, S., Speciale, C., & Varasi, M. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00517-4 · Cited by 32
Saito, K., Markey, S. P., & Heyes, M. P. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90761-7 · Cited by 30
Uptake of 3-hydroxykynurenine measured in rat brain slices and in a neuronal cell line
Eastman, C. L., Guilarte, T. R., & Lever, J. R. (1992) · Brain Research · doi:10.1016/0006-8993(92)90883-b · Cited by 29
Linderberg, M. (1999) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(99)00220-2 · Cited by 24
The “Kynurenate Test,” a Biochemical Assay for Putative Cognition Enhancers
Pittaluga, A., Vaccari, D., & Raiteri, M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37010-7 · Cited by 23
S-Aryl cysteine S,S-dioxides as inhibitors of mammalian kynureninase
Drysdale, M. J., & Reinhard, J. F. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)10209-8 · Cited by 21
Novel tryptophan dioxygenase inhibitors and combined tryptophan dioxygenase/5-HT reuptake inhibitors
Madge, D. J., Hazelwood, R., Iyer, R. N., Jones, H. T., & Salter, M. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00124-2 · Cited by 18
Peterson, A. C., Loggia, A. J. L., Hamaker, L. K., Arend, R. A., Fisette, P. L., Ozaki, Y., Will, J., Brown, R. R., & Cook, J. M. (1994) · ChemInform · doi:10.1002/chin.199435294 · Cited by 16
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
“In addition, based on the differential expression of relevant metabolic enzymes, KYN is preferentially converted to kynurenic acid (KA) in astrocytes and quinolinic acid (QUIN) in microglia (Figure 1)(36).”
InfluentialMammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Self-citationYing, W. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1672 · Cited by 1,494
“Thus, the kynurenine pathway has been a target for treatment of multiple neurological diseases (206, 249, 255).”
Metadata
- Authors
- Schwarcz, R., & Pellicciari, R.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 303
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2120276500
- Cited by
- 556
- References
- 62
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.